v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 24, 2026
Sep. 25, 2025
Operating activities    
Net income $ 200,402 $ 169,316
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 187,200 180,492
Stock-based compensation expense 24,557 22,372
Deferred income taxes (13,066) (23,937)
Loss on extinguishment of debt 1,328 0
Changes in operating assets and liabilities:    
Receivables, net (29,600) (4,223)
Inventories, net (40,000) (31,562)
Trade accounts payable 115,864 (73,765)
Accrued expenses and other current liabilities 15,545 22,533
Income taxes 30,044 9,431
Deferred revenue 3,479 (178)
Other, net (10,445) (12,711)
Net cash provided by operating activities 485,308 257,768
Investing activities    
Purchases of fixed assets (187,918) (238,839)
Net cash used in investing activities (187,918) (238,839)
Financing activities    
Proceeds from term loan 200,000 0
Payments on term loan (198,190) (1,577)
Payments of debt issuance costs (7,571) 0
Payments of contingent earn-out liabilities (750) (806)
Proceeds from exercise of stock options 10,207 3,061
Proceeds from employee stock purchase plan 5,217 5,970
Tax payments for stock-based compensation awards (6,022) (8,762)
Payments for repurchase of common stock (157,093) 0
Net cash used in financing activities (154,202) (2,114)
Net increase in cash and cash equivalents 143,188 16,815
Cash and cash equivalents, beginning of the period 249,296 187,669
Cash and cash equivalents, end of the period 392,484 204,484
Supplemental disclosures of cash flow information    
Buildings and equipment acquired under operating leases 118,728 399,656
Cash paid for interest, net of capitalized interest 9,083 7,084
Cash paid for income taxes, net of refunds 35,676 59,846
Fixed assets accrued at the end of the period $ 45,965 $ 64,846